書目名稱 | Delivery Systems for Peptide Drugs | 編輯 | S. S. Davis,Lisbeth Illum,E. Tomlinson | 視頻video | http://file.papertrans.cn/266/265004/265004.mp4 | 叢書名稱 | NATO Science Series A: | 圖書封面 |  | 描述 | Recent years have seen enormous advances in the field of protein and peptide engineering and a greater understanding in the way in which biological response modifiers function in the body. It is now possible through the use of recombinant DNA techniques, or by solid phase protein synthesis, to produce significant quantities of a wide variety of regulatory agents that are therapeutically applicable. The list of these response modifiers expands almost daily to include interferons, macrophage activation factors, neuropeptides and agents that may have potential in cardiovascular disease, inflammation, contraception etc. Prospects to use some of these materials in medicine have reached the stage where products have either been approved by regulatory authorities or are the subject of applications as investigatory drugs or as new therapeutic agents. In some uses the pertinent agent will be administered on an acute basis in the form of a simple injection, as, for example, the use of a tissue plasminogen activator for the treatment of coronary infarct. In other cases regulatory proteins and peptides are indicated for chronic therapy and here they will need to be administered by an appropria | 出版日期 | Book 1986 | 關(guān)鍵詞 | absorption; biotechnology; cardiovascular disease; drug; drug delivery; inflammation; interferon; life scie | 版次 | 1 | doi | https://doi.org/10.1007/978-1-4757-9960-6 | isbn_softcover | 978-1-4757-9962-0 | isbn_ebook | 978-1-4757-9960-6 | copyright | Springer Science+Business Media New York 1986 |
The information of publication is updating
|
|